These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 741421)

  • 21. Prednacinolone, a new anti-inflammatory steroid. 1. Chemical and physical properties.
    Mantica L; Ciceri R; Assagne JP; Mascitelli-Coriandoli E
    Arzneimittelforschung; 1970 Jan; 20(1):109-10. PubMed ID: 5467433
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose inhaled steroids in asthmatic children.
    Brus RH; Bodenheimer S
    Lancet; 1996 Sep; 348(9030):820-1; author reply 821. PubMed ID: 8813997
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
    Woodford R
    Arch Dermatol; 1986 Dec; 122(12):1355. PubMed ID: 3789765
    [No Abstract]   [Full Text] [Related]  

  • 24. Corticosteroid ointments: comparison by two human bioassays.
    Burdick KH; Haleblian JK; Poulsen BJ; Cobner SE
    Curr Ther Res Clin Exp; 1973 May; 15(5):233-42. PubMed ID: 4196783
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cutaneus vasoconstrictive effect of mineralocorticoids].
    Weirich EG; Lutz U
    Arch Dermatol Forsch; 1974; 250(4):359-68. PubMed ID: 4447377
    [No Abstract]   [Full Text] [Related]  

  • 26. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
    Brehm K; Maucher OM
    Arzneimittelforschung; 1972 Jun; 22(6):1038-9. PubMed ID: 5068352
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of synemol cream and other topical corticosteroid creams using the vasoconstrictor bioassay.
    Strand LJ; Flatman CJ; Northway CS; Evans CD
    Cutis; 1977 May; 19(5):689-91. PubMed ID: 862429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 29. Tachyphylaxis to the action of topically applied corticosteroids.
    du Vivier A; Stoughton RB
    Arch Dermatol; 1975 May; 111(5):581-3. PubMed ID: 1130802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Penetration kinetics of topical steroids].
    Tronnier H
    Arch Klin Exp Dermatol; 1970; 237(3):769-73. PubMed ID: 5523569
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
    Täuber VU; Amin M; Fuchs P; Speck U
    Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
    Ishikawa H; Mori Y; Tsurufuji S
    Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of tropical application of steroids on the skin].
    Tagami H
    Hifuka Kiyo; 1971 Feb; 66(1):1-45. PubMed ID: 5170320
    [No Abstract]   [Full Text] [Related]  

  • 35. The systemic and local effects of dexamethasone, triamcinolone, 6 alpha-fluorotriamcinolone, and certain of their derivatives, compared by reference to their influence on the foreign-body granuloma, on the weight of the adrenals and thymus, and on the rate of weight gain.
    Desaulles PA; Samsel J
    Hormones; 1971; 2(4):204-15. PubMed ID: 5006661
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacodynamic and metabolic characteristics of a new dermosteroid: Formocortal].
    Sala G; Castegnaro E
    G Ital Dermatol Minerva Dermatol; 1970 Jul; 45(7):451-62. PubMed ID: 5537424
    [No Abstract]   [Full Text] [Related]  

  • 37. [The influence of vehicule composition and corticosteroids sensitivity on the vasoconstrictor activity of a new topical corticosteroid, difluprednate (author's transl)].
    Girard J; Sagon J; Barbier A; Tardieu JC; Lafille C
    J Pharm Belg; 1978; 33(6):341-50. PubMed ID: 748519
    [No Abstract]   [Full Text] [Related]  

  • 38. Paper-patch test for evaluating vasoconstrictive activity of corticosteroids.
    Falconi G; Rossi GL
    Arch Dermatol; 1972 Jun; 105(6):856-8. PubMed ID: 5030235
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
    Thalén A; Brattsand R; Andersson PH
    Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative pharmacological activity of triamcinolone acetonide and of a new topical steroid: amcinonide, after percutaneous or oral administration (author's transl)].
    Wepierre J; Bogaievsky Y
    J Pharmacol; 1980; 11(4):449-62. PubMed ID: 7206733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.